To Be Discontinued Tablet Reproductive
Drospirenone; Ethinyl Estrad · 497 days since initial FDA posting
Brand: OCELLA
FDA lists Drospirenone; Ethinyl Estrad as To Be Discontinued (Teva Pharmaceuticals USA, Inc.).
No availability text on this FDA row.
Drospirenone; Ethinyl Estradiol Tablet: To Be Discontinued
FDA availability text is not recorded on this row. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Drospirenone; Ethinyl Estradiol Tablet
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Dosage Form
- Tablet
- Presentation
- Ocella, Tablet, Kit (NDC 0555-9131-67)
- Package NDC
- 0555-9131-67
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- May 2, 2025
- Last Updated
- May 2, 2025
- Therapeutic Category
- Reproductive
Row fields from the FDA Drug Shortages database via openFDA.